The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Apr. 30, 4:38 PM

Slide #3. Biocept, Inc. Secondary Offering

Company: Biocept, Inc. (NASDAQ:BIOC)
Date announced: 4/28/2016
Shares Offered: 5,000,000
Date of Pricing: 4/29/2016
Price Per Share: $1.00
Secondary Offering Details: Biocept, Inc. ("Biocept") (Nasdaq: BIOC) today announced a proposed registered public offering of its common stock and warrants, subject to market and other conditions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. -updated 4/29- Biocept, Inc. ("Biocept") (Nasdaq: BIOC) today announced that it has priced a registered public offering of an aggregate of approximately 5.0 million shares of common stock at a price to the public of $1.00 per share. Investors will also receive warrants to purchase up to an aggregate of approximately 3.5 million shares of common stock with an exercise price of $1.30 per share. The warrants are immediately exercisable and have a term of five years. The offering is expected to close on or about May 4, 2016, subject to satisfaction of customary closing conditions.

Biocept ia a commercial-stage cancer diagnostics company developing and commercializing circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) tests utilizing a standard blood sample for used by oncologists to select the treatment for patients. Co.'s OncoCEE-BR breast cancer test utilize its Cell Enrichment and Extraction technology for the analysis of CTCs, and its CEE-Selector technology for the detection and analysis of ctDNA. Co. also has a research and development program focused on technology enhancements and platform development and a translational research group evaluating clinical applications for cancer diagnostic tests in different cancer types and clinical settings.
Open the BIOC Page at The Online Investor »

Company Name:  Biocept, Inc
Website:  www.biocept.com
Sector:  Diagnostics
Number of ETFs Holding BIOC:  2
Total Market Value Held by ETFs:  $41944
Total Market Capitalization:  $26.00M
% of Market Cap. Held by ETFs:  0.16%
 

Open the BIOC Page at The Online Investor (in a new window) »

April 30, 2016    4:38 PM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
87th percentile
(ranked higher than approx. 87% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.